Cargando…
The Calcium-Sensing Receptor (CaSR) Variants at rs1801725 Increase the Risk of Developing Secondary Malignant Cancers
The dysregulation of systemic calcium homeostasis during malignancy is common in most patients with high-grade tumors. The associated comorbidity is known as cancer-induced hypercalcemia (CIH) which affects up to 30% of cases, in the absence of metastasis. In the course of breast cancer progression,...
Autores principales: | Beasley, Heather K, Actkins, Ky’Era, Annika, Faucon, Davis, Lea, Sakwe, Amos M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089630/ http://dx.doi.org/10.1210/jendso/bvab048.544 |
Ejemplares similares
-
Calcium-Sensing Receptor Polymorphisms at rs1801725 Are Associated with Increased Risk of Secondary Malignancies
por: Actkins, Ky’Era V., et al.
Publicado: (2021) -
OR07-06 The Roles of GNAQ and GNA11 in Calcium-Sensing Receptor (CaSR) Signalling
por: Gluck, Anna K, et al.
Publicado: (2020) -
SAT-350 A Tale of Two Mutations: Familial Hypocalciuric Hypercalcemia Caused by a Novel CaSR Start Codon Mutation Found in the Setting of a CaSR Hypercalciuric Variant
por: Bandaru, Sindhura, et al.
Publicado: (2020) -
SAT217 Chronic Asymptomatic Hypoparathyroidism Due To Two Separate Single Nucleotide Heterozygous Mutations In The CaSR Gene
por: Anto Antony, Mc, et al.
Publicado: (2023) -
OR03-05 Cinacalcet Acts As A Spatially Biased Allosteric Modulator To Enhance CaSR Signaling From Endosomal Membranes
por: Wyatt, Rachael, et al.
Publicado: (2023)